Meropenem plus Ertapenem and Ceftazidime–Avibactam plus Aztreonam for the Treatment of Ventilator Associated Pneumonia Caused by Pan-Drug Resistant <i>Klebsiella pneumonia</i>

Meropenem plus Ertapenem and Ceftazidime–Avibactam plus Aztreonam for the Treatment of Ventilator Associated Pneumonia Caused by Pan-Drug Resistant <i>Klebsiella pneumonia</i>

Introduction: Gram-negative bacteria (GNB) account for about 70% of infections in the intensive care unit (ICU) setting and are associated with significant morbidity and mortality. In recent years, pan-drug resistant (PDR) strains, strains that are not susceptible to any antibiotic, have been emerge...

Full description

Bibliographic Details
Main Authors: Konstantinos Mantzarlis, Efstratios Manoulakas, Kyriaki Parisi, Evaggelia Sdroulia, Nikolaos Zapaniotis, Vassiliki Tsolaki, Epaminondas Zakynthinos, Demosthenes Makris
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Antibiotics
Subjects:
pan-drug resistant <i>K. pneumonia</i>
ceftazidime–avibactam + aztreonam treatment
double carbapenem therapy
ventilator associated pneumonia (VAP)
survival
mechanical ventilation
Online Access:https://www.mdpi.com/2079-6382/13/2/141

Internet

https://www.mdpi.com/2079-6382/13/2/141

Similar Items